ArticleJournal of computer-aided molecular design2026
Oxidation-derived metabolites sustain the antioxidant network of quercetin.
Article in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Quercetin is a widely consumed dietary flavonoid and nutraceutical with diverse biological activities, yet the mechanisms underlying its potent antioxidant effects remain incompletely understood. This study aims to examine the hypothesis that quercetin's antioxidant efficacy is associated with a unique coordinating network in which radical-derived oxidation metabolites retain reducing capacity, supporting successive scavenging reactions and potentially contributing to selected regulatory pathways. To investigate this hypothesis, oxidation metabolites were first generated using 2,2-diphenyl-1-picrylhydrazyl as a readily monitored and well-controlled radical oxidant. The reaction mixture was separated using an Agilent 1290 Infinity ultrahigh-performance liquid chromatography system with a water-acetonitrile gradient. Metabolites of interest were then characterized using a quadrupole time-of-flight tandem mass spectrometer in negative-ion mode and annotated based on [M-H]⁻ and fragmentation patterns. Electronic-structure and thermodynamic calculations based on density functional theory (DFT) were performed to evaluate frontier molecular orbitals and the mechanistic feasibility of the common antioxidant pathways. These results indicate that these metabolites can retain, and in some cases exceed the radical-scavenging capacity of the parent molecule. Network pharmacology analysis and molecular docking further suggest that these metabolites potentially engage a substantial portion of quercetin's core regulatory targets and may contribute to its broader biological effects. Notably, among these metabolites, 2-benzoyl-2-hydroxy-3(2H)-benzofuranones emerged as promise. Explanatorily, time-dependent density functional theory (TD-DFT) analysis further suggested that the formation of successively reactive metabolites may be facilitated by the characteristic excited-state intramolecular proton-transfer mechanism of flavonols. These findings warrant further investigation of oxidation metabolites within quercetin's antioxidant network.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.